Milrinone is an intravenous phosphodiesterase III inhibitor classified as an inotrope and vasodilator, primarily used for the short-term treatment of acute decompensated heart failure. To support pharmaceutical… Read more


![Chemical structure of 2'-Methyl-6'-oxo-1',6'-dihydro-[2,3'-bipyridine]-5'-carbonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F106637-42-7-2-Methyl-6-oxo-16-dihydro-23-bipyridine-5-carbonitrile.png&w=3840&q=75)

![Chemical structure of 5-Cyano-1,6-dihydro-6-oxo-[3,4'-bipyridine]-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F98293-81-3-5-Cyano-16-dihydro-6-oxo-34-bipyridine-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of 5-Cyano-2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine] 1'-Oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F156033-07-7-5-Cyano-2-methyl-6-oxo-16-dihydro-34-bipyridine-1-Oxide.png&w=3840&q=75)


![Chemical structure of Methyl 2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1443528-66-2-Methyl-2-methyl-6-oxo-16-dihydro-34-bipyridine-5-carboxylate.png&w=3840&q=75)


Milrinone is an intravenous phosphodiesterase III inhibitor classified as an inotrope and vasodilator, primarily used for the short-term treatment of acute decompensated heart failure. To support pharmaceutical analysis, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, its known pharmacopeial and non-pharmacopeial impurities, and various degradation products. These materials are essential for rigorous impurity profiling, enabling laboratories to identify and quantify potential by-products during manufacturing and stability testing. The collection also features metabolites such as Milrinone O-glucuronide and stable isotope labelled standards, including deuterated and 13C-labelled forms. These labelled compounds serve as internal standards for mass spectrometry-based assays, ensuring accuracy in method validation and quality control procedures. By utilizing these high-quality reference materials, researchers and analysts can reliably verify the chemical integrity and safety of Milrinone formulations throughout the drug development lifecycle.